Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 18.06
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research, development, production, and sale of Chinese medicines, APIs, and preparations. It also develops medical devices, including orthopaedic implant devices, medical equipment, and protective equipment, as well as disposable bacteria medical polymer consumables; and provides hospital engineering services. The company was formerly known as Wanbangde New...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Data is available to registered users only
Buy
Sell